Provided by Tiger Trade Technology Pte. Ltd.

LANGAR GLOBAL HEALTHTECH ETF

9.74
+0.09090.94%
Post-market: 9.770.0276+0.28%16:10 EDT
Volume:383
Turnover:4K
Market Cap:2.24M
PE:- -
High:9.77
Open:9.77
Low:9.74
Close:9.65
52wk High:11.01
52wk Low:7.97
Shares:230.00K
Float Shares:230.00K
Volume Ratio:0.59
T/O Rate:0.17%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.91
ROE:--
ROA:--
PB:--
PE(LYR):5.11

Loading ...

BrainAurora lifts revenue as it deepens push into AI cognitive digital therapeutics

TIPRANKS
·
Aug 28

Moderna Stock Falls on $2B Notes Deal: Is the Cancer Rally Still Intact?

TradingKey
·
Aug 28

Argus Research Upgrades Moderna to Buy From Hold, $180 Price Target

MT Newswires Live
·
Aug 28

Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes

Reuters
·
Aug 28

Moderna Price Target Announced at $180.00/Share by Argus Research

Dow Jones
·
Aug 28

U.S. Stocks on the MOVE-Cytokinetics, Moderna, Ulta Beauty

Reuters
·
Aug 28

Success After a Century of Failures: Inside Moderna and Merck's Cancer Vaccine Breakthrough

Reuters
·
Aug 28

GE HealthCare Adds Three Cardiovascular Ultrasound Systems for Heart Imaging

MT Newswires Live
·
Aug 28

Moderna Prices $2.6 Billion Convertible Notes due 2032

MT Newswires Live
·
Aug 28

Moderna Rises After Upsized $2.6 Bln Convertible Bond Sale

Reuters
·
Aug 28

GE HealthCare Wins CE Mark for New Vivid Ultrasound Systems, EchoPAC V211

Reuters
·
Aug 28

Veeva Systems Inc. : Citigroup Raises Target Price to $273 from $190

THOMSON REUTERS
·
Aug 28

Veeva Systems (VEEV) Stock Rallies As Profit Growth Sharpens Execution Story

Simply Wall St.
·
Aug 28

Lr 1.15.3 Compliance-Rmd.n

Reuters
·
Aug 28

FDA Approves Seasonal Covid-19 Vaccines from Moderna, Pfizer, BioNTech

Dow Jones
·
Aug 28

GE HealthCare Technologies Inc. Stock Falls Thursday, Underperforms Market

Dow Jones
·
Aug 28

Moderna Inc. Stock Slips 4.6%, Underperforms Peers

Dow Jones
·
Aug 28

ResMed CEO Farrell, CFO Bloomer to Present at Morgan Stanley Global Healthcare Conference

Reuters
·
Aug 28

Moderna Wins FDA Approval for Updated 2026-2027 COVID-19 Vaccines Targeting JN.1-Lineage XFG Subvariant

Reuters
·
Aug 28

Moderna - FDA Approved Sbla for 2026-2027 Formulas for Spikevax and Mnexspike

THOMSON REUTERS
·
Aug 28